← Back to headlines
Lantheus says FDA extended review period for radioactive diagnostic kit
Lantheus announced that the FDA has extended the review period for its radioactive diagnostic kit.
Sources
Showing 0 of 1 sources
Related Stories
The doctor is in: Skin cancer rates in Ireland are predicted to rise - how can you avoid it?
9m ago
F.D.A. Investigates 7 E. Coli Illnesses as Raw Dairy Farm Denies Any Link
13m ago
Death toll at start of Covid-19 pandemic likely higher than US count, study says
15m ago
Katarzia o zmrazení vajíčok: Netúžim po dieťati, ale racionálne uvažujem, že to raz môže prísť
22m ago